Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
Minoryx Therapeutics has raised $31.5M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Minoryx Therapeutics's investors include European Investment Bank, Columbus Venture Partners, Ysios Capital, Inveready, Kurma Partners.
Minoryx Therapeutics is headquartered in Barcelona, Spain.
Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
Minoryx Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Minoryx Therapeutics — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/minoryx-therapeutics. Accessed September 29, 2026.
VCBacked. (2025). Minoryx Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/minoryx-therapeutics
{{cite web |title=Minoryx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/minoryx-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated